Global Super Generic Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Super Generic Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Super Generic Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Super Generic Drugs by Country/Region, 2017, 2022 & 2028

2.2 Super Generic Drugs Segment by Type

2.2.1 Traditional Generic Drugs

2.2.2 Biosimilars

2.3 Super Generic Drugs Sales by Type

2.3.1 Global Super Generic Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Super Generic Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Super Generic Drugs Sale Price by Type (2017-2022)

2.4 Super Generic Drugs Segment by Application

2.4.1 CNS

2.4.2 Cardiovascular

2.4.3 Genitourinary/Hormonal Drugs

2.4.4 Respiratory

2.4.5 Rheumatology

2.4.6 Diabetes

2.4.7 Oncology

2.4.8 Others

2.5 Super Generic Drugs Sales by Application

2.5.1 Global Super Generic Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Super Generic Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Super Generic Drugs Sale Price by Application (2017-2022)

3 Global Super Generic Drugs by Company

3.1 Global Super Generic Drugs Breakdown Data by Company

3.1.1 Global Super Generic Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Super Generic Drugs Sales Market Share by Company (2020-2022)

3.2 Global Super Generic Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Super Generic Drugs Revenue by Company (2020-2022)

3.2.2 Global Super Generic Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Super Generic Drugs Sale Price by Company

3.4 Key Manufacturers Super Generic Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Super Generic Drugs Product Location Distribution

3.4.2 Players Super Generic Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Super Generic Drugs by Geographic Region

4.1 World Historic Super Generic Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Super Generic Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Super Generic Drugs Annual Revenue by Geographic Region

4.2 World Historic Super Generic Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Super Generic Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Super Generic Drugs Annual Revenue by Country/Region

4.3 Americas Super Generic Drugs Sales Growth

4.4 APAC Super Generic Drugs Sales Growth

4.5 Europe Super Generic Drugs Sales Growth

4.6 Middle East & Africa Super Generic Drugs Sales Growth

5 Americas

5.1 Americas Super Generic Drugs Sales by Country

5.1.1 Americas Super Generic Drugs Sales by Country (2017-2022)

5.1.2 Americas Super Generic Drugs Revenue by Country (2017-2022)

5.2 Americas Super Generic Drugs Sales by Type

5.3 Americas Super Generic Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Super Generic Drugs Sales by Region

6.1.1 APAC Super Generic Drugs Sales by Region (2017-2022)

6.1.2 APAC Super Generic Drugs Revenue by Region (2017-2022)

6.2 APAC Super Generic Drugs Sales by Type

6.3 APAC Super Generic Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Super Generic Drugs by Country

7.1.1 Europe Super Generic Drugs Sales by Country (2017-2022)

7.1.2 Europe Super Generic Drugs Revenue by Country (2017-2022)

7.2 Europe Super Generic Drugs Sales by Type

7.3 Europe Super Generic Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Super Generic Drugs by Country

8.1.1 Middle East & Africa Super Generic Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Super Generic Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Super Generic Drugs Sales by Type

8.3 Middle East & Africa Super Generic Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Super Generic Drugs

10.3 Manufacturing Process Analysis of Super Generic Drugs

10.4 Industry Chain Structure of Super Generic Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Super Generic Drugs Distributors

11.3 Super Generic Drugs Customer

12 World Forecast Review for Super Generic Drugs by Geographic Region

12.1 Global Super Generic Drugs Market Size Forecast by Region

12.1.1 Global Super Generic Drugs Forecast by Region (2023-2028)

12.1.2 Global Super Generic Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Super Generic Drugs Forecast by Type

12.7 Global Super Generic Drugs Forecast by Application

13 Key Players Analysis

13.1 Teva

13.1.1 Teva Company Information

13.1.2 Teva Super Generic Drugs Product Offered

13.1.3 Teva Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Main Business Overview

13.1.5 Teva Latest Developments

13.2 Novartis - Sandoz

13.2.1 Novartis - Sandoz Company Information

13.2.2 Novartis - Sandoz Super Generic Drugs Product Offered

13.2.3 Novartis - Sandoz Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis - Sandoz Main Business Overview

13.2.5 Novartis - Sandoz Latest Developments

13.3 Mylan

13.3.1 Mylan Company Information

13.3.2 Mylan Super Generic Drugs Product Offered

13.3.3 Mylan Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Main Business Overview

13.3.5 Mylan Latest Developments

13.4 Sun Pharmaceutical

13.4.1 Sun Pharmaceutical Company Information

13.4.2 Sun Pharmaceutical Super Generic Drugs Product Offered

13.4.3 Sun Pharmaceutical Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sun Pharmaceutical Main Business Overview

13.4.5 Sun Pharmaceutical Latest Developments

13.5 Aspen

13.5.1 Aspen Company Information

13.5.2 Aspen Super Generic Drugs Product Offered

13.5.3 Aspen Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Aspen Main Business Overview

13.5.5 Aspen Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Super Generic Drugs Product Offered

13.6.3 Fresenius Kabi Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Pfizer (Hospira)

13.7.1 Pfizer (Hospira) Company Information

13.7.2 Pfizer (Hospira) Super Generic Drugs Product Offered

13.7.3 Pfizer (Hospira) Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer (Hospira) Main Business Overview

13.7.5 Pfizer (Hospira) Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Super Generic Drugs Product Offered

13.8.3 Sanofi Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Aurobindo

13.9.1 Aurobindo Company Information

13.9.2 Aurobindo Super Generic Drugs Product Offered

13.9.3 Aurobindo Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Aurobindo Main Business Overview

13.9.5 Aurobindo Latest Developments

13.10 Lupin

13.10.1 Lupin Company Information

13.10.2 Lupin Super Generic Drugs Product Offered

13.10.3 Lupin Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Lupin Main Business Overview

13.10.5 Lupin Latest Developments

13.11 Dr. Reddy's

13.11.1 Dr. Reddy's Company Information

13.11.2 Dr. Reddy's Super Generic Drugs Product Offered

13.11.3 Dr. Reddy's Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Dr. Reddy's Main Business Overview

13.11.5 Dr. Reddy's Latest Developments

13.12 Apotex

13.12.1 Apotex Company Information

13.12.2 Apotex Super Generic Drugs Product Offered

13.12.3 Apotex Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Apotex Main Business Overview

13.12.5 Apotex Latest Developments

13.13 Cipla

13.13.1 Cipla Company Information

13.13.2 Cipla Super Generic Drugs Product Offered

13.13.3 Cipla Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Cipla Main Business Overview

13.13.5 Cipla Latest Developments

13.14 ENDO (Par Pharmaceutical)

13.14.1 ENDO (Par Pharmaceutical) Company Information

13.14.2 ENDO (Par Pharmaceutical) Super Generic Drugs Product Offered

13.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 ENDO (Par Pharmaceutical) Main Business Overview

13.14.5 ENDO (Par Pharmaceutical) Latest Developments

13.15 Stada Arzneimittel

13.15.1 Stada Arzneimittel Company Information

13.15.2 Stada Arzneimittel Super Generic Drugs Product Offered

13.15.3 Stada Arzneimittel Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Stada Arzneimittel Main Business Overview

13.15.5 Stada Arzneimittel Latest Developments

13.16 Krka Group

13.16.1 Krka Group Company Information

13.16.2 Krka Group Super Generic Drugs Product Offered

13.16.3 Krka Group Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Krka Group Main Business Overview

13.16.5 Krka Group Latest Developments

13.17 Nichi-Iko Pharmaceutical

13.17.1 Nichi-Iko Pharmaceutical Company Information

13.17.2 Nichi-Iko Pharmaceutical Super Generic Drugs Product Offered

13.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Nichi-Iko Pharmaceutical Main Business Overview

13.17.5 Nichi-Iko Pharmaceutical Latest Developments

13.18 Valeant

13.18.1 Valeant Company Information

13.18.2 Valeant Super Generic Drugs Product Offered

13.18.3 Valeant Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Valeant Main Business Overview

13.18.5 Valeant Latest Developments

13.19 Zydus Cadila

13.19.1 Zydus Cadila Company Information

13.19.2 Zydus Cadila Super Generic Drugs Product Offered

13.19.3 Zydus Cadila Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Zydus Cadila Main Business Overview

13.19.5 Zydus Cadila Latest Developments

13.20 Hikma

13.20.1 Hikma Company Information

13.20.2 Hikma Super Generic Drugs Product Offered

13.20.3 Hikma Super Generic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Hikma Main Business Overview

13.20.5 Hikma Latest Developments

14 Research Findings and Conclusion

Table 1. Super Generic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Super Generic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Traditional Generic Drugs

Table 4. Major Players of Biosimilars

Table 5. Global Super Generic Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Super Generic Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Super Generic Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Super Generic Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Super Generic Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Super Generic Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Super Generic Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Super Generic Drugs Revenue by Application (2017-2022)

Table 13. Global Super Generic Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Super Generic Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Super Generic Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Super Generic Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Super Generic Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Super Generic Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Super Generic Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Super Generic Drugs Producing Area Distribution and Sales Area

Table 21. Players Super Generic Drugs Products Offered

Table 22. Super Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Super Generic Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Super Generic Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Super Generic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Super Generic Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Super Generic Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Super Generic Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Super Generic Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Super Generic Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Super Generic Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Super Generic Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Super Generic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Super Generic Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Super Generic Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Super Generic Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Super Generic Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Super Generic Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Super Generic Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Super Generic Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Super Generic Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Super Generic Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Super Generic Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Super Generic Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Super Generic Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Super Generic Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Super Generic Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Super Generic Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Super Generic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Super Generic Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Super Generic Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Super Generic Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Super Generic Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Super Generic Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Super Generic Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Super Generic Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Super Generic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Super Generic Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Super Generic Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Super Generic Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Super Generic Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Super Generic Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Super Generic Drugs

Table 66. Key Market Challenges & Risks of Super Generic Drugs

Table 67. Key Industry Trends of Super Generic Drugs

Table 68. Super Generic Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Super Generic Drugs Distributors List

Table 71. Super Generic Drugs Customer List

Table 72. Global Super Generic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Super Generic Drugs Sales Market Forecast by Region

Table 74. Global Super Generic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Super Generic Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Super Generic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Super Generic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Super Generic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Super Generic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Super Generic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Super Generic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Super Generic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Super Generic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Super Generic Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Super Generic Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Super Generic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Super Generic Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Super Generic Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Super Generic Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Super Generic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Super Generic Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Teva Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Teva Super Generic Drugs Product Offered

Table 94. Teva Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Teva Main Business

Table 96. Teva Latest Developments

Table 97. Novartis - Sandoz Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Novartis - Sandoz Super Generic Drugs Product Offered

Table 99. Novartis - Sandoz Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Novartis - Sandoz Main Business

Table 101. Novartis - Sandoz Latest Developments

Table 102. Mylan Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Mylan Super Generic Drugs Product Offered

Table 104. Mylan Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Mylan Main Business

Table 106. Mylan Latest Developments

Table 107. Sun Pharmaceutical Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Sun Pharmaceutical Super Generic Drugs Product Offered

Table 109. Sun Pharmaceutical Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Sun Pharmaceutical Main Business

Table 111. Sun Pharmaceutical Latest Developments

Table 112. Aspen Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Aspen Super Generic Drugs Product Offered

Table 114. Aspen Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Aspen Main Business

Table 116. Aspen Latest Developments

Table 117. Fresenius Kabi Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Fresenius Kabi Super Generic Drugs Product Offered

Table 119. Fresenius Kabi Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Fresenius Kabi Main Business

Table 121. Fresenius Kabi Latest Developments

Table 122. Pfizer (Hospira) Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Pfizer (Hospira) Super Generic Drugs Product Offered

Table 124. Pfizer (Hospira) Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Pfizer (Hospira) Main Business

Table 126. Pfizer (Hospira) Latest Developments

Table 127. Sanofi Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Sanofi Super Generic Drugs Product Offered

Table 129. Sanofi Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Sanofi Main Business

Table 131. Sanofi Latest Developments

Table 132. Aurobindo Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Aurobindo Super Generic Drugs Product Offered

Table 134. Aurobindo Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Aurobindo Main Business

Table 136. Aurobindo Latest Developments

Table 137. Lupin Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Lupin Super Generic Drugs Product Offered

Table 139. Lupin Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Lupin Main Business

Table 141. Lupin Latest Developments

Table 142. Dr. Reddy's Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Dr. Reddy's Super Generic Drugs Product Offered

Table 144. Dr. Reddy's Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Dr. Reddy's Main Business

Table 146. Dr. Reddy's Latest Developments

Table 147. Apotex Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Apotex Super Generic Drugs Product Offered

Table 149. Apotex Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Apotex Main Business

Table 151. Apotex Latest Developments

Table 152. Cipla Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Cipla Super Generic Drugs Product Offered

Table 154. Cipla Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Cipla Main Business

Table 156. Cipla Latest Developments

Table 157. ENDO (Par Pharmaceutical) Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. ENDO (Par Pharmaceutical) Super Generic Drugs Product Offered

Table 159. ENDO (Par Pharmaceutical) Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. ENDO (Par Pharmaceutical) Main Business

Table 161. ENDO (Par Pharmaceutical) Latest Developments

Table 162. Stada Arzneimittel Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Stada Arzneimittel Super Generic Drugs Product Offered

Table 164. Stada Arzneimittel Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Stada Arzneimittel Main Business

Table 166. Stada Arzneimittel Latest Developments

Table 167. Krka Group Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Krka Group Super Generic Drugs Product Offered

Table 169. Krka Group Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Krka Group Main Business

Table 171. Krka Group Latest Developments

Table 172. Nichi-Iko Pharmaceutical Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Nichi-Iko Pharmaceutical Super Generic Drugs Product Offered

Table 174. Nichi-Iko Pharmaceutical Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Nichi-Iko Pharmaceutical Main Business

Table 176. Nichi-Iko Pharmaceutical Latest Developments

Table 177. Valeant Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. Valeant Super Generic Drugs Product Offered

Table 179. Valeant Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Valeant Main Business

Table 181. Valeant Latest Developments

Table 182. Zydus Cadila Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. Zydus Cadila Super Generic Drugs Product Offered

Table 184. Zydus Cadila Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Zydus Cadila Main Business

Table 186. Zydus Cadila Latest Developments

Table 187. Hikma Basic Information, Super Generic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Hikma Super Generic Drugs Product Offered

Table 189. Hikma Super Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Hikma Main Business

Table 191. Hikma Latest Developments

List of Figures

Figure 1. Picture of Super Generic Drugs

Figure 2. Super Generic Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Super Generic Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Super Generic Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Super Generic Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Traditional Generic Drugs

Figure 10. Product Picture of Biosimilars

Figure 11. Global Super Generic Drugs Sales Market Share by Type in 2021

Figure 12. Global Super Generic Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Super Generic Drugs Consumed in CNS

Figure 14. Global Super Generic Drugs Market: CNS (2017-2022) & (K Units)

Figure 15. Super Generic Drugs Consumed in Cardiovascular

Figure 16. Global Super Generic Drugs Market: Cardiovascular (2017-2022) & (K Units)

Figure 17. Super Generic Drugs Consumed in Genitourinary/Hormonal Drugs

Figure 18. Global Super Generic Drugs Market: Genitourinary/Hormonal Drugs (2017-2022) & (K Units)

Figure 19. Super Generic Drugs Consumed in Respiratory

Figure 20. Global Super Generic Drugs Market: Respiratory (2017-2022) & (K Units)

Figure 21. Super Generic Drugs Consumed in Rheumatology

Figure 22. Global Super Generic Drugs Market: Rheumatology (2017-2022) & (K Units)

Figure 23. Super Generic Drugs Consumed in Diabetes

Figure 24. Global Super Generic Drugs Market: Diabetes (2017-2022) & (K Units)

Figure 25. Super Generic Drugs Consumed in Oncology

Figure 26. Global Super Generic Drugs Market: Oncology (2017-2022) & (K Units)

Figure 27. Super Generic Drugs Consumed in Others

Figure 28. Global Super Generic Drugs Market: Others (2017-2022) & (K Units)

Figure 29. Global Super Generic Drugs Sales Market Share by Application (2017-2022)

Figure 30. Global Super Generic Drugs Revenue Market Share by Application in 2021

Figure 31. Super Generic Drugs Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Super Generic Drugs Revenue Market Share by Company in 2021

Figure 33. Global Super Generic Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Super Generic Drugs Revenue Market Share by Geographic Region in 2021

Figure 35. Global Super Generic Drugs Sales Market Share by Region (2017-2022)

Figure 36. Global Super Generic Drugs Revenue Market Share by Country/Region in 2021

Figure 37. Americas Super Generic Drugs Sales 2017-2022 (K Units)

Figure 38. Americas Super Generic Drugs Revenue 2017-2022 ($ Millions)

Figure 39. APAC Super Generic Drugs Sales 2017-2022 (K Units)

Figure 40. APAC Super Generic Drugs Revenue 2017-2022 ($ Millions)

Figure 41. Europe Super Generic Drugs Sales 2017-2022 (K Units)

Figure 42. Europe Super Generic Drugs Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Super Generic Drugs Sales 2017-2022 (K Units)

Figure 44. Middle East & Africa Super Generic Drugs Revenue 2017-2022 ($ Millions)

Figure 45. Americas Super Generic Drugs Sales Market Share by Country in 2021

Figure 46. Americas Super Generic Drugs Revenue Market Share by Country in 2021

Figure 47. United States Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Super Generic Drugs Sales Market Share by Region in 2021

Figure 52. APAC Super Generic Drugs Revenue Market Share by Regions in 2021

Figure 53. China Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Super Generic Drugs Sales Market Share by Country in 2021

Figure 60. Europe Super Generic Drugs Revenue Market Share by Country in 2021

Figure 61. Germany Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Super Generic Drugs Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Super Generic Drugs Revenue Market Share by Country in 2021

Figure 68. Egypt Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Super Generic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Super Generic Drugs in 2021

Figure 74. Manufacturing Process Analysis of Super Generic Drugs

Figure 75. Industry Chain Structure of Super Generic Drugs

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles